Healthcare

NOX

Noxopharm completes enrolment for the dose expansion arm in DARRT-1 study

Noxopharm Limited (ASX: NOX) recently announced the enrolment of 12th patient  into the dose-expansion arm of DARRT-1 study, which is the company’s first clinical...

Why The Market Opportunity For This ASX Biotech Has Expanded Significantly This Month

Cancer treatment developer Invion Limited (ASX: IVX) could be at an important crossroad as the market opportunity for the company may have more than...
MGC Pharmaceuticals’ Shares Surged Over 5% Post Material Revenue Confirmation

MGC Pharmaceuticals’ Shares Surged Over 5% Post Material Revenue Confirmation

Today, on 4th June 2019, a European based ‘Seed to Pharmacy’ bio-pharma company, MGC Pharmaceuticals Ltd (ASX: MXC) announced its operations and confirmation of...

PolyNovo Records Yet another Million-dollar Month

PolyNovo Limited (ASX: PNV) is a developer of medical devices, headquartered in Melbourne. The company designs, progresses and produces dermal regeneration solutions, with the...

Medical Developments Bags Distribution Rights For Penthrox®; Stock Trading In The Range

Medical Developments International Limited (ASX: MVP) is an ASX listed healthcare company providing emergency medical solutions. The company is a leader in emergency pain...
GID

GI Dynamics® Board considering potential ASX Delisting

GI Dynamics® Inc (ASX: GID) is a company from the health care sector, developing EndoBarrier® (not approved for sale and limited by federal law...

LBT Innovations Entered Trading Halt Ahead of Capital Raising Announcement

Headquartered in Australia, LBT Innovations Limited (ASX: LBT) specialises in bringing advanced medical technologies to market. The company designs advanced technology solutions for the...
IHL

Impression Healthcare Inks Product Supply Agreement with AXIM Biotechnologies

Impression Healthcare Limited (ASX: IHL) is an Australia registered company involved in manufacturing and marketing of home-impression custom-fit mouthguards. The company, by release, updated...

Starpharma Makes Second Deal With AstraZeneca For Development Of Oncology Medicine

Starpharma Holdings Limited (ASX: SPL) is a global lead which develops dendrimer products for pharmaceutical, life science and other applications. Located in Melbourne, its...

CLINUVEL PHARMACEUTICALS’s Drug SCENESSE® Goal Date Extended By The US FDA

CLINUVEL PHARMACEUTICALS LTD (ASX: CUV) is a global biopharmaceutical player. It concentrates on developing and providing treatments for severe genetic and skin disorders. The...

Recent Posts